最新消息
News & Message
:::
Silmitasertib Plus Gemcitabine and Cisplatin First-Line Therapy in Locally Advanced/Metastatic Cholangiocarcinoma: a Phase 1b/2 Study
Tislelizumab plus chemotherapy versus placebo plus chemotherapy as first-line treatment for advanced or metastatic oesophageal squamous cell carcinoma (RATIONALE-306): a global, randomised, placebo-controlled, phase 3 study.
Safety, Efficacy, and Pharmacokinetics of SHR-A1811, a Human Epidermal Growth Factor Receptor 2-Directed Antibody-Drug Conjugate, in Human Epidermal Growth Factor Receptor 2-Expressing or Mutated Advanced Solid Tumors: A Global Phase I Trial
2025/2/4
Ivosidenib and Azacitidine in IDH1-Mutated Acute Myeloid Leukemia
Ivosidenib and Azacitidine in IDH1-Mutated Acute Myeloid Leukemia
作者群：Montesinos P, Recher C, Vives S, Zarzycka E, Wang J, Bertani G, Heuser M, Calado RT, Schuh AC, Yeh SP (葉士芃), Daigle SR, Hui J, Pandya SS, Gianolio DA, de Botton S, Döhner H.
期刊：N Engl J Med
出版年月：2022
圖片來源：N Engl J Med
相關文章
開關
首頁
Facebook
Instagram
體系醫院
中國醫點通